The medical device and diagnostics industries are facing significant challenges on issues ranging from Medicare reimbursement rates, insurance coverage and new Federal taxes. At that same time, technological innovation is opening doors to a number of new diagnostics that are likely to fulfill the promise of personalized medicine. Caliber Advisors has significant experience with the key considerations to valuing industry participants.
Practice highlights include:
Valuation of diagnostics companies for the identification and treatment of:
- nervous system disorders
Valuation of device manufacturers including
- spine and orthotic devices,
- portable oxygen systems,
- dental implants,
- optical devices, and
- pulse, laser and ultrasound skin treatment devices.